Details for New Drug Application (NDA): 017630
✉ Email this page to a colleague
NDA 017630 describes SODIUM IODIDE I 123, which is a drug marketed by Cardinal Health 418, Curium, and Ge Healthcare, and is included in four NDAs. It is available from two suppliers. Additional details are available on the SODIUM IODIDE I 123 profile page.
The generic ingredient in SODIUM IODIDE I 123 is sodium iodide i-123. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-123 profile page.
The generic ingredient in SODIUM IODIDE I 123 is sodium iodide i-123. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-123 profile page.
Summary for 017630
| Tradename: | SODIUM IODIDE I 123 |
| Applicant: | Ge Healthcare |
| Ingredient: | sodium iodide i-123 |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 100uCi | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 2mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 200uCi | ||||
| Approval Date: | Jan 8, 1993 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
